Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3571 AL 3585

Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease

Sehlin D, Fang XT, Cato L, Antoni G, Lannfelt L, Syvänen S.

Nat Commun. 2016 Feb 19;7:10759. doi: 10.1038/ncomms10759.

Pseudobulbar Affect or Depression in Dementia?

Chang YD, Davis MP, Smith J, Gutgsell T.

J Pain Symptom Manage. 2016 May;51(5):954-8. doi: 10.1016/j.jpainsymman.2015.12.321. Epub 2016 Feb 17.

Cognitive Decline in Presymptomatic Alzheimer Disease

Howieson DB.

JAMA Neurol. 2016 Apr;73(4):384-5. doi: 10.1001/jamaneurol.2015.4993.

Editorial: Translational Alzheimer's Disease Research

Huang Y, Lahiri DK.

Curr Alzheimer Res. 2016;13(3):214. doi: 10.2174/156720501303160217102238.

Could Aesthetic Surgery Impact Alzheimer's Risk?

Nahai F.

Aesthet Surg J. 2016 Jul;36(7):858-9. doi: 10.1093/asj/sjw039. Epub 2016 Feb 23.

Donepezil 23 mg in Asian patients with moderate-to-severe Alzheimer's disease

Han SH, Lee JH, Kim SY, Park KW, Chen C, Tripathi M, Dash A, Kubota N.

Acta Neurol Scand. 2017 Feb;135(2):252-256. doi: 10.1111/ane.12571. Epub 2016 Feb 29.

A path analysis of patient dependence and caregiver burden in Alzheimer's disease

Garre-Olmo J, Vilalta-Franch J, Calvó-Perxas L, Turró-Garriga O, Conde-Sala L, López-Pousa S.

Int Psychogeriatr. 2016 Jul;28(7):1133-41. doi: 10.1017/S1041610216000223. Epub 2016 Mar 1.

Meaningful activities for improving the wellbeing of people with dementia: beyond mere pleasure to meeting fundamental psychological needs

Nyman SR, Szymczynska P.

Perspect Public Health. 2016 Mar;136(2):99-107. doi: 10.1177/1757913915626193.

Evaluation of a mobile team dedicated to behavioural disorders as recommended by the Alzheimer Cooperative Valuation in Europe joint action: observational cohort study

Krolak-Salmon P, Roubaud C, Finne-Soveri H, Riolacci-Dhoyen N, Richard G, Rouch I, Leperre-Desplanques A, Dauphinot V.

Eur J Neurol. 2016 May;23(5):979-88. doi: 10.1111/ene.12975. Epub 2016 Mar 6.

Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease

Pasquier F, Sadowsky C, Holstein A, Leterme Gle P, Peng Y, Jackson N, Fox NC, Ketter N, Liu E, Ryan JM; ACC-001 (QS-21) Study Team.

J Alzheimers Dis. 2016;51(4):1131-43. doi: 10.3233/JAD-150376.

Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1

Sanders C, Behrens S, Schwartz S, Wengreen H, Corcoran CD, Lyketsos CG, Tschanz JT.

J Alzheimers Dis. 2016 Feb 27;52(1):33-42. doi: 10.3233/JAD-150528.

Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study

Florian H, Meier A, Gauthier S, Lipschitz S, Lin Y, Tang Q, Othman AA, Robieson WZ, Gault LM.

J Alzheimers Dis. 2016;51(4):1237-47. doi: 10.3233/JAD-150978.

Diabetes and Alzheimer's disease crosstalk

Baglietto-Vargas D, Shi J, Yaeger DM, Ager R, LaFerla FM.

Neurosci Biobehav Rev. 2016 May;64:272-87. doi: 10.1016/j.neubiorev.2016.03.005. Epub 2016 Mar 9.

Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy

Paterson RW, Abdi Z, Haines A, Schott JM.

Clin Neurol Neurosurg. 2016 May;144:64-6. doi: 10.1016/j.clineuro.2016.02.036. Epub 2016 Mar 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias